Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Biceps Tenodesis for Superior Labrum Anterior-Posterior Tear in the Overhead Athlete: A Systematic Review
Frantz, Travis L. , Shacklett, Andrew G., Martin, Adam S. , Jones, Grant L. , Neviaser, Andrew S. , Cvetanovich, Gregory L. , Barlow, Jonathan D.

Mayo Clinic

The American Journal of Sports Medicine | June 24, 2020 | Volume: 49 | Issue: 2 | Pages: 522-528

10.1177/0363546520921177 | PMID 32579853 Get It

Background: Superior labrum anterior-posterior (SLAP) lesion is a common shoulder injury, particularly in overhead athletes. While surgical management has traditionally consisted of SLAP repair, high rates of revision and complications have led to alternative techniques, such as biceps tenodesis (BT). While BT is commonly reserved for older nonoverhead athletes, indications for its use have expanded in recent years. Purpose: To determine functional outcomes and return-to-sport rates among overhead athletes after BT for SLAP tear. Study Design: Systematic review. Methods: A systematic review was performed for any articles published before July 2019. The search phrase “labral tear” was used to capture maximum results, followed by keyword inclusion of “SLAP tear” and “biceps tenodesis.” Inclusion criteria included outcome studies of BT for isolated SLAP tear in athletes participating in any overhead sports, not limited to throwing alone. Abstracts and manuscripts were independently reviewed to determine eligibility. When clearly delineated, outcome variables from multiple studies were combined. Results: After full review, 8 articles met inclusion criteria (99 athletes; mean age, 19.8-47 years), with baseball and softball players the most common among them (n = 62). Type II SLAP tear was the most common diagnosis, and 0% to 44% of athletes had a failed previous SLAP repair before undergoing BT. Only 1 study included patients with concomitant rotator cuff repair. Open subpectoral BT was most commonly used, and complication rates ranged from 0% to 14%, with wound erythema, traumatic biceps tendon rupture, brachial plexus neurapraxia, and adhesive capsulitis being reported. Combined reported postoperative functional scores were as follows: American Shoulder and Elbow Surgeons, 81.7 to 97; 12-Item Short Form Health Survey physical, 50 to 54; visual analog scale for pain, 0.8-1.5; Kerlan Jobe Orthopaedic Clinic, 66 to 79; and satisfaction, 80% to 87%. The overall return-to-sports rate for overhead athletes was 70% (60 of 86). For studies that clearly delineated outcomes based on level of play/athlete, the combined return-to-sports rate was 69% (11 of 16) for recreational overhead athletes, 80% (4 of 5) for competitive/collegiate athletes, and 60% (18 of 30) for professionals. Conclusion: BT in the overhead athlete offers encouraging functional outcomes and return-to-sports rates, particularly in the recreational athlete. It can be successfully performed as an index operation rather than SLAP repair, as well as in a younger patient population. Careful consideration should be given to elite overhead athletes, particularly pitchers, who tend to experience poorer outcomes.
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance
Clay‐Gilmour, Alyssa , Brown, Elizabeth E. , Spinelli, John J. , Giles, Graham G. , Bhatti, Parveen , Wu, Xifeng , Waller, Rosalie G., Belachew, Alem A. , Robinson, Dennis P. , Sinnwell, Jason P. , Berndt, Sonja I. , Kumar, Shaji , Machiela, Mitchell J. , Camp, Nicola J. , Vachon, Celine M. , Waller, Rosalie G. , Griffin, R. L. , Clay-Gilmour, Alyssa I, Norman, Aaron D. , Giles, Graham G , Sinnwell, Jason P , Bhatti, Parveen , Waller, Rosalie G , Machiela, Mitchell J , Griffin, Rosalie , Hildebrandt, Michelle A.T. , Hofmann, Jonathan N. , Cozen, Wendy , Waller, Rosalie G., Rajkumar, S. Vincent , Chanock, Stephen Jacob , Milne, Roger L. , Slager, Susan L. , Ziv, Elad , Vachon, Celine M.

Mayo Clinic

Blood Advances | June 22, 2020 | Volume: 4 | Issue: 12 | Pages: 2789-2797

10.1182/bloodadvances.2020001435 | PMID 32569378 Get It

Abstract So far, 23 germline susceptibility loci have been associated with multiple myeloma (MM) risk. It is unclear whether the genetic variation associated with MM susceptibility also predisposes to its precursor, monoclonal gammopathy of undetermined significance (MGUS). Leveraging 2434 MM cases, 754 MGUS cases, and 2 independent sets of controls (2567/879), we investigated potential shared genetic susceptibility of MM and MGUS by (1) performing MM and MGUS genome-wide association studies (GWAS); (2) validating the association of a polygenic risk score (PRS) based on 23 established MM loci (MM-PRS) with risk of MM, and for the first time with MGUS; and (3) examining genetic correlation of MM and MGUS. Heritability and genetic estimates yielded 17% (standard error [SE] ±0.04) and 15% (SE ±0.11) for MM and MGUS risk, respectively, and a 55% (SE ±0.30) genetic correlation. The MM-PRS was associated with risk of MM when assessed continuously (odds ratio [OR], 1.17 per SD; 95% confidence interval [CI], 1.13-1.21) or categorically (OR, 1.70; 95% CI, 1.38-2.09 for highest; OR, 0.71; 95% CI, 0.55-0.90 for lowest compared with middle quintile). The MM-PRS was similarly associated with MGUS (OR, 1.19 per SD; 95% CI, 1.14-1.26 as a continuous measure, OR, 1.77, 95%CI: 1.29-2.43 for highest and OR, 0.70, 95%CI: 0.50-0.98 for lowest compared with middle quintile). MM and MGUS associations did not differ by age, sex, or MM immunoglobulin isotype. We validated a 23-SNP MM-PRS in an independent series of MM cases and provide evidence for its association with MGUS. Our results suggest shared common genetic susceptibility to MM and MGUS.
Have you ever experienced a headache of any kind?
Smith, Jonathan H.

Mayo Clinic

Cephalalgia | June 21, 2020 | Volume: 40 | Issue: 10 | Pages: 1132-1133

10.1177/0333102420933978 | PMID 32567338 Get It

Tracheostomy Post Liver Transplant: Predictors, Complications, and Outcomes
Graham, Ryan C. , Bush, Weston, Mella, Jeffrey , Ekser, Burcin , Mihaylov, Plamen , Bush, Weston J, Ekser, Burcin , Fridell, Jonathan A. , Kubal, Chandrashekhar A. , Mangus, Richard Shane

Mayo Clinic

Annals of Transplantation | June 19, 2020 | Volume: 25 | Issue: No issue available | Pages: No page available

10.12659/aot.920630 | PMID 32778638 Get It

Anticoagulation Use During Dorsal Column Spinal Cord Stimulation Trial
D’Souza, Ryan S. , Hagedorn, Jonathan M. , Hagedorn, Jonathan M , D'Souza, Ryan S

Mayo Clinic

Pain Medicine | June 18, 2020 | Volume: 21 | Issue: 10 | Pages: 2595-2598

10.1093/pm/pnaa244 | PMID 32797241 Get It

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
Song, Honglin , Dicks, Ed , Intermaggio, Maria P., Chenevix‐Trench, Georgia , Bowtell, David D.L. , Traficante, Nadia , Group, AOCS, Hosking, Karen, Piskorz, Anna , Oudenhove, Elke Van , Doherty, J.A. , Rossing, Mary Anne, Duerst, Matthias, Dörk, Thilo , Bogdanova, Natalia , Moysich, Kirsten B. , Odunsi, Kunle , Ness, Roberta B., Lester, Jenny, Pujara, Miguel Angel, Cunningham, Julie M. , Hildebrandt, Michelle, Huff, Chad , Li, Donghui , Wu, Xifeng , Yu, Yao , Levine, Douglas A. , Schildkraut, Joellen M. , Riggan, Marjorie J. , Webb, Penelope M. , Group, OPAL Study, Jakubowska, Anna , Alsop, Jennifer , Harrington, Patricia, Chan, Isaac H Y , Menon, Usha , Pearce, Celeste Leigh, Wu, Anna H. , Fazio, Anna de , Kennedy, Catherine J. , Goode, Ellen L. , Ramus, Susan J. , Gayther, Simon A. , DeFazio, Anna , Cunningham, Julie, Vierkant, Robert, Huff, Chad , Cybulski, Cezary , Pharoah, Paul D P , Dörk, Thilo , Ramus, Susan J , Webb, Penelope M , Menon, Usha , Moysich, Kirsten , Kennedy, Catherine J , Jakubowska, Anna , Bogdanova, Natalia V , Chenevix-Trench, Georgia , Traficante, Nadia , Bowtell, David D , Tyrer, Jonathan P. , Group, AOCS, Brenton, James D. , Goranova, Teodora , Harris, Holly R. , Modugno, Francesmary , Karlan, Beth Y. , Jensen, Allan , Kjær, Susanne K. , Høgdall, Estrid , Campbell, Ian , Lázaro, Conxi , Vierkant, Robert A. , Winham, Stacey J. , Permuth, Jennifer B. , Berchuck, Andrew , Cybulski, Cezary , Gronwald, Jacek , Lubiński, Jan , Pharoah, Paul D.P.

Mayo Clinic

Journal of Medical Genetics | June 16, 2020 | Volume: 58 | Issue: 5 | Pages: 305-313

10.1136/jmedgenet-2019-106739 | PMID 32546565 Get It

Purpose The known epithelial ovarian cancer (EOC) susceptibility genes account for less than 50% of the heritable risk of ovarian cancer suggesting that other susceptibility genes exist. The aim of this study was to evaluate the contribution to ovarian cancer susceptibility of rare deleterious germline variants in a set of candidate genes. Methods We sequenced the coding region of 54 candidate genes in 6385 invasive EOC cases and 6115 controls of broad European ancestry. Genes with an increased frequency of putative deleterious variants in cases versus controls were further examined in an independent set of 14 135 EOC cases and 28 655 controls from the Ovarian Cancer Association Consortium and the UK Biobank. For each gene, we estimated the EOC risks and evaluated associations between germline variant status and clinical characteristics. Results The ORs associated for high-grade serous ovarian cancer were 3.01 for PALB2 (95% CI 1.59 to 5.68; p=0.00068), 1.99 for POLK (95% CI 1.15 to 3.43; p=0.014) and 4.07 for SLX4 (95% CI 1.34 to 12.4; p=0.013). Deleterious mutations in FBXO10 were associated with a reduced risk of disease (OR 0.27, 95% CI 0.07 to 1.00, p=0.049). However, based on the Bayes false discovery probability, only the association for PALB2 in high-grade serous ovarian cancer is likely to represent a true positive. Conclusions We have found strong evidence that carriers of PALB2 deleterious mutations are at increased risk of high-grade serous ovarian cancer. Whether the magnitude of risk is sufficiently high to warrant the inclusion of PALB2 in cancer gene panels for ovarian cancer risk testing is unclear; much larger sample sizes will be needed to provide sufficiently precise estimates for clinical counselling.
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis
Carter, Jonathan L, Valencia-Sánchez, Cristina

Mayo Clinic

Expert Opinion on Pharmacotherapy | June 16, 2020 | Volume: 21 | Issue: 12 | Pages: 1399-1405

10.1080/14656566.2020.1763304 | PMID 32543241 Get It

High Patient Disease Burden in a Cross‐sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases
Jensen, Elizabeth T. , Aceves, Seema S. , Bonis, Peter A, Bray, Kimberly, Book, Wendy , Chehade, Mirna , Dellon, Evan S. , Gonsalves, Nirmala , Gupta, Sandeep K. , Hirano, Ikuo , Katzka, David A. , Kyle, Shay, Mack, Denise, Kodroff, Ellyn, Leung, John , Scott, Melissa, Paliana, Ally, Sable, Kathleen, Strobel, Mary Jo, Krischer, Jeffrey P. , group, CEGIR Investigator, Collins, Margaret H. , Falk, Gary W. , Mukkada, Vincent A. , Spergel, Jonathan M. , Rothenberg, Marc E. , Abonia, J. Pablo , group, CEGIR Investigator

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | June 15, 2020 | Volume: 71 | Issue: 4 | Pages: 524-529

10.1097/mpg.0000000000002817 | PMID 32541201 Get It

ABSTRACT Objectives: Clinical features of eosinophilic esophagitis (EoE) have been well‐described in the literature, however, characterization of features experienced by patients with other eosinophilic gastrointestinal diseases (EGIDs) is lacking. Using data collected from a patient contact registry, we sought to characterize and contrast patient‐reported gastrointestinal and extragastrointestinal symptoms and comorbidities in non‐EoE EGIDs, including eosinophilic gastritis, gastroenteritis and colitis, relative to EoE. Methods: We conducted a cross‐sectional study of contact registry data collected from 2015 to 2018. Statistical comparisons were made using chi‐square (categorical measures) and the Mann‐Whitney U test (continuous measures). Multivariable analyses were used to evaluate associations between treatment and feelings of isolation. Results: Of the 715 reporting an EGID diagnosis (n = 525 EoE; n = 190 non‐EoE EGID), a higher proportion of those with a non‐EoE EGID reported more frequent specific and nonspecific gastrointestinal symptoms, including nausea, abdominal pain, diarrhea, constipation, and bloating ( P < 0.01 for all). Participants with a non‐EoE EGID were more likely to report higher frequency of fatigue, isolation, and deep muscle or joint pain ( P < 0.01 for all). Specific food elimination and elemental formula treatments were associated with increased odds of more frequent (at least weekly) feelings of isolation for participants with EoE (adjusted odds rtaio [aOR]: 2.4; 95% confidence interval [CI]: 1.5‐‐4.1 for specific food elimination and adjusted OR: 1.9; 95% CI: 1.2‐‐3.3 for elemental formula). Conclusions: Significant differences exist in the symptoms and comorbidities experienced between those with EoE versus non‐EoE EGIDs. Additional investigation is needed to elucidate the factors that may contribute to the high disease burden of these poorly understood conditions.